Literature DB >> 15731073

Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice.

C Scott Little1, Andrew Bowe, Richard Lin, Jason Litsky, Robert M Fogel, Brian J Balin, Kerin L Fresa-Dillon.   

Abstract

The intracellular bacterium Chlamydophila ("Chlamydia") pneumoniae is a pathogen for several respiratory diseases and may be a factor in the pathogenesis of chronic diseases of aging including atherosclerosis and Alzheimer's disease. We assessed whether aging is coupled with increased burden of infection in BALB/c mice after intranasal infection by C. pneumoniae. Six- and twenty-month-old BALB/c mice were infected intranasally with 5 x 10(4) inclusion forming units (IFU) or 5 x 10(5) IFU of C. pneumoniae. Lung, brain, and heart tissue were analyzed for infectious C. pneumoniae and for Chlamydophila antigen by immunohistochemistry. At both doses, aging was associated with a decreased proportion of animals that cleared infection from the lung and greater burden of infectious organism within the lung. We observed dose-dependent spread to the heart/ascending aorta in animals infected with C. pneumoniae. In mice given 5 x 10(4) IFU, spread to the heart by day 14 was only observed in old mice. By day 28, all animals inoculated with 5 x 10(4) IFU showed evidence of spread to the heart, although higher C. pneumoniae titers were observed in the hearts from old mice. In mice inoculated with 5 x 10(5) IFU, spread of C. pneumoniae to the heart was evident by day 14, with no discernible age effect. C. pneumoniae was also recovered from the central nervous system (brain and olfactory bulb) of all mice by day 28 postinfection, with higher C. pneumoniae titers in old animals than in young animals. Our results suggest that infection with C. pneumoniae may be more severe in old animals.

Entities:  

Mesh:

Year:  2005        PMID: 15731073      PMCID: PMC1064908          DOI: 10.1128/IAI.73.3.1723-1734.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Severe meningoencephalitis: an unusual manifestation of Chlamydia pneumoniae infection.

Authors:  J Guglielminotti; N Lellouche; E Maury; M Alzieu; B Guidet; G Offenstadt
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

2.  Trends in causes of death among the elderly.

Authors:  N R Sahyoun; H Lentzner; D Hoyert; K N Robinson
Journal:  Aging Trends       Date:  2001-03

Review 3.  Chlamydia pneumoniae and chronic lung diseases.

Authors:  A L Laurila; L Von Hertzen; P Saikku
Journal:  Scand J Infect Dis Suppl       Date:  1997

4.  Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  T C Moazed; L A Campbell; M E Rosenfeld; J T Grayston; C C Kuo
Journal:  J Infect Dis       Date:  1999-07       Impact factor: 5.226

Review 5.  Chlamydia pneumoniae and coronary heart disease.

Authors:  S S Carlisle; M C Nahata
Journal:  Ann Pharmacother       Date:  1999-05       Impact factor: 3.154

6.  Chlamydia pneumoniae as a triggering infection in reactive arthritis.

Authors:  T Hannu; M Puolakkainen; M Leirisalo-Repo
Journal:  Rheumatology (Oxford)       Date:  1999-05       Impact factor: 7.580

7.  Atherosclerosis in apoE knockout mice infected with multiple pathogens.

Authors:  M S Burnett; C A Gaydos; G E Madico; S M Glad; B Paigen; T C Quinn; S E Epstein
Journal:  J Infect Dis       Date:  2000-12-21       Impact factor: 5.226

8.  Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma.

Authors:  Antonio Gigliotti Rothfuchs; Maria Regina Kreuger; Hans Wigzell; Martin E Rottenberg
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

9.  Prevalence of chlamydia pneumoniae in Japanese rural districts; association of smoking and physical activity with Chlamydia pneumoniae seropositivity.

Authors:  Masafumi Mizooka; Shizukiyo Ishikawa
Journal:  Intern Med       Date:  2003-10       Impact factor: 1.271

10.  The chlamydial pneumonias.

Authors:  B A Cunha
Journal:  Drugs Today (Barc)       Date:  1998-12       Impact factor: 2.245

View more
  13 in total

Review 1.  Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?

Authors:  Kensuke Shima; Gregor Kuhlenbäumer; Jan Rupp
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

Review 2.  Microbes and Alzheimer's Disease.

Authors:  Ruth F Itzhaki; Richard Lathe; Brian J Balin; Melvyn J Ball; Elaine L Bearer; Heiko Braak; Maria J Bullido; Chris Carter; Mario Clerici; S Louise Cosby; Kelly Del Tredici; Hugh Field; Tamas Fulop; Claudio Grassi; W Sue T Griffin; Jürgen Haas; Alan P Hudson; Angela R Kamer; Douglas B Kell; Federico Licastro; Luc Letenneur; Hugo Lövheim; Roberta Mancuso; Judith Miklossy; Carola Otth; Anna Teresa Palamara; George Perry; Christopher Preston; Etheresia Pretorius; Timo Strandberg; Naji Tabet; Simon D Taylor-Robinson; Judith A Whittum-Hudson
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 3.  Sepsis in old age: review of human and animal studies.

Authors:  Marlene E Starr; Hiroshi Saito
Journal:  Aging Dis       Date:  2014-04-01       Impact factor: 6.745

4.  Effect of age and vaccination on extent and spread of Chlamydia pneumoniae infection in C57BL/6 mice.

Authors:  Taylor Eddens; Sarah Beaudoin; Amanda Steinberger; C Scott Little; Dawn Shell; Benjamin Wizel; Brian Balin; Kerin L Fresa-Dillon
Journal:  Immun Ageing       Date:  2012-05-17       Impact factor: 6.400

5.  Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain.

Authors:  Christine J Hammond; Loretta R Hallock; Raymond J Howanski; Denah M Appelt; C Scott Little; Brian J Balin
Journal:  BMC Neurosci       Date:  2010-09-23       Impact factor: 3.288

Review 6.  Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview.

Authors:  Marisa Di Pietro; Simone Filardo; Fiorenzo De Santis; Rosa Sessa
Journal:  Int J Mol Sci       Date:  2013-07-19       Impact factor: 5.923

7.  Detection of bacterial antigens and Alzheimer's disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae.

Authors:  Christopher S Little; Timothy A Joyce; Christine J Hammond; Hazem Matta; David Cahn; Denah M Appelt; Brian J Balin
Journal:  Front Aging Neurosci       Date:  2014-12-05       Impact factor: 5.750

8.  Chlamydia pneumoniae Clinical Isolate from Gingival Crevicular Fluid: A Potential Atherogenic Strain.

Authors:  Simone Filardo; Marisa Di Pietro; Giovanna Schiavoni; Gianluca Minniti; Emanuela Ortolani; Silvio Romano; Rosa Sessa
Journal:  Front Cell Infect Microbiol       Date:  2015-11-25       Impact factor: 5.293

Review 9.  Role of Microbes in the Development of Alzheimer's Disease: State of the Art - An International Symposium Presented at the 2017 IAGG Congress in San Francisco.

Authors:  Tamàs Fülöp; Ruth F Itzhaki; Brian J Balin; Judith Miklossy; Annelise E Barron
Journal:  Front Genet       Date:  2018-09-10       Impact factor: 4.599

Review 10.  Chlamydia pneumoniae: An Etiologic Agent for Late-Onset Dementia.

Authors:  Brian J Balin; Christine J Hammond; Christopher Scott Little; Susan T Hingley; Zein Al-Atrache; Denah M Appelt; Judith A Whittum-Hudson; Alan P Hudson
Journal:  Front Aging Neurosci       Date:  2018-10-09       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.